PENN MEDICINE CO-INVESTMENT PROGRAM
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
PENN MEDICINE CO-INVESTMENT PROGRAM
Industry:
Biopharma Biotechnology Health Care Life Science
Status:
Active
Similar Organizations
Accelerate@Babraham
Accelerate@Babraham is the incubation programme of the Babraham Research Campus.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Molecular Forecaster
Molecular Forecaster builds software for drug discovery, metabolism prediction, library design & small molecule asymmetric catalyst design.
Recognify Life Sciences
Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").
Reliance Life Sciences
Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies
Sharp Corp
Sharp Corp provides contract packaging services for Rx, biotechnology, OTC/nutritional, clinical packaging, animal health.
Global Health Investment Fund (GHIF)
Impact investment fund established to finance late-stage development of new drugs, vaccines and diagnostics for public health challenges
Tricol Biomedical Inc
Tricol Biomedical develops advanced wound care, hemorrhage, infection control & wound management technologies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Vittoria Biotherapeutics | Penn Medicine Co-Investment Program investment in Seed Round - Vittoria Biotherapeutics | 10 M USD |
| 2021-11-30 | CareAlign | Penn Medicine Co-Investment Program investment in Seed Round - CareAlign | 2.3 M USD |
| 2021-05-18 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-03-01 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Carisma Therapeutics | 12 M USD |
| 2020-03-13 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Venture Round - Interius BioTherapeutics | 5.5 M USD |
| 2019-10-31 | Tmunity Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Tmunity Therapeutics | 75 M USD |
| 2019-09-17 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Linnaeus Therapeutics | 12 M USD |
| 2019-01-03 | Cabaletta Bio | Penn Medicine Co-Investment Program investment in Series B - Cabaletta Bio | 50 M USD |
| 2018-09-07 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Linnaeus Therapeutics | 4.4 M USD |
| 2018-06-27 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Carisma Therapeutics | 53 M USD |
More informations about "Penn Medicine Co-Investment Program"
Penn Medicine Co-Investment Program continues to thrive
Jun 21, 2022 Launched in March 2018, the Penn Medicine Co-Investment Program assists faculty entrepreneurs as they move along the path to venture creation and permanent …See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program is funding platform for cell and gene therapy, mRNA, lipid nanoparticle, and health technologies. Philadelphia, Pennsylvania, United States; 10001+ …See details»
The Path from Innovation to Implementation - Penn Medicine
Penn and Greater Philadelphia’s Entrepreneurial …
Penn Ecosystem Besides the support available for entrepreneurial activities through PCI, PCIV and the Pennovation Center, there are a broad array of centers and programs across the University that can support faculty and …See details»
Penn Medicine Co-Investment Program - raizer.app
Penn Medicine Co-Investment Program invests in cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health spinouts from Penn Learn which startups Penn Medicine …See details»
Penn Medicine Co-Investment Program - PitchBook
Jan 26, 2023 Penn Medicine Co-Investment Program's latest investment was on 12-Aug-2024 in Linnaeus Therapeutics, a company within the Drug Discovery industry. Data Transparency. …See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program has made 6 diversity investments. Their most recent diversity investment was on Nov 30, 2021 , when CareAlign raised obfuscatedSee details»
Carter Caldwell - Program Director @ Penn Medicine Co …
As the Penn Medicine Co-Investment Program’s Director, Carter drives Penn Medicine's investments in the cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health …See details»
R. Carter Caldwell - Penn Center for Innovation
As the Penn Medicine Co-Investment Program Director, Carter leads Penn Medicine’s investments in the cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health sectors. Utilizing multiple decades of …See details»
Wharton Fund for Health’s Portfolio - Penn Medicine
Aug 2, 2022 The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first …See details»
PENN MEDICINE CO-INVESTMENT PROGRAM DIRECTOR - Inside …
Duties: The Program Director will manage a co-investment pilot Program which will enable University participation in early financing rounds in companies created through licenses of …See details»
Carter Caldwell of the Penn Medicine Co-Investment Program: …
Apr 20, 2023 In 2019, I joined a brand new investment vehicle that Penn Medicine at the University of Pennsylvania set up to fund spinouts that emerge from faculty research.See details»
Carter Caldwell | The Venture Debt Conference
As the Penn Medicine Co-Investment Program Director at the University of Pennsylvania, Carter leads Penn Medicine's investments in the cell therapy, gene therapy, mRNA, lipid …See details»
Carter Caldwell - Penn Medicine, University of Pennsylvania Health ...
As the Penn Medicine Co-Investment Program Director, Carter leads Penn Medicine's… · Experience: Penn Medicine, University of Pennsylvania Health System · Education: Columbia …See details»
Penn Medicine Co-Investment Program: Fund Performance
Information on investments, limited partners, investment strategy, team and returns for Penn Medicine Co-Investment Program. Use the PitchBook Platform to explore the full profile.See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program is funding platform for cell and gene therapy, mRNA, lipid nanoparticle, and health technologies.See details»
Choosing the University of Pennsylvania for Its ... - Penn Medicine
Guest post from Carter Caldwell. Carter Caldwell is the Co-Investment Program Director at Penn Medicine. I chose to attend the University of Pennsylvania for my undergrad for its excellence …See details»
PCI Team Member and Penn Medicine Featured in Washington Post
Nov 1, 2022 Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey …See details»
White Paper: Forging a Path Toward Integrated Care for Dually …
Nov 21, 2024 Acknowledgements . This paper and companion policy brief is based on a public conference and closed-door expert convening held at Penn in July 2024 co-hosted by the …See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program . Connect to CRM . Save . Summary. Investments. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 6. …See details»